- Home
- CDTX vs KAI Comparison
CDTX vs KAI Comparison
Compare CDTX & KAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CDTX | KAI |
|---|---|---|
| Founded | 2012 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 3.3B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | CDTX | KAI |
|---|---|---|
| Price | $220.50 | $289.69 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 2 |
| Target Price | $128.75 | ★ $340.00 |
| AVG Volume (30 Days) | ★ 2.3M | 141.0K |
| Earning Date | 11-06-2025 | 10-28-2025 |
| Dividend Yield | N/A | ★ 0.47% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 8.65 |
| Revenue | N/A | ★ $1,024,074,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $10.56 |
| P/E Ratio | ★ N/A | $33.78 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $15.22 | $244.87 |
| 52 Week High | $221.20 | $409.73 |
Technical Indicators
Market Signals| Indicator | CDTX | KAI |
|---|---|---|
| Relative Strength Index (RSI) | 86.62 | 57.58 |
| Support Level | $219.60 | $276.80 |
| Resistance Level | $220.38 | $300.44 |
| Average True Range (ATR) | 0.74 | 9.69 |
| MACD | -3.92 | 2.66 |
| Stochastic Oscillator | 67.82 | 72.75 |
Price Performance
Historical ComparisonAbout CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About KAI Kadant Inc
Kadant Inc. supplies process and engineering equipment for papermaking, recycling, lumber manufacturing, and related industries. The company's three reportable segments are the Flow Control segment which consists of the fluid-handling and doctoring, cleaning, & filtration product lines; the Industrial Processing segment which consists of the wood processing and stock-preparation product lines; and Material handling systems, which provides conveyor-belt equipment for industries such as mining, food processing, and packaging. The company has a geographic presence in the U.S., China, Asia, Germany, Canada, and Others.